Scientists deliberately give flu to volunteers to speed up vaccine research
NCT ID NCT07110532
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 38 times
Summary
This study aims to find the right dose of a specific flu virus that safely causes mild flu symptoms in healthy adults aged 18 to 55. About 90 volunteers will receive either the virus or a sham (placebo) and be closely monitored. The goal is to create a reliable human infection model for testing future flu vaccines and treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Vaccine and Trials Unit
RECRUITINGDurham, North Carolina, 27710, United States
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
RECRUITINGBaltimore, Maryland, 21201-1509, United States
Conditions
Explore the condition pages connected to this study.